Global Chronic Kidney Disease (CKD) Drugs Market Insights and Forecast to 2026

Publisher Name :
Date: 14-Aug-2020
No. of pages: 113
Inquire Before Buying

Chronic Kidney Disease (CKD) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease (CKD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Chronic Kidney Disease (CKD) Drugs market is segmented into

- ACE inhibitors

- Angiotensin-II receptor blockers

- Calcium channel blockers

- Beta blockers: BREVIBLOC, Bystolic

- Others

Segment by Application, the Chronic Kidney Disease (CKD) Drugs market is segmented into

- Hospitals

- Specialty Clinics

Regional and Country-level Analysis

The Chronic Kidney Disease (CKD) Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Chronic Kidney Disease (CKD) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Chronic Kidney Disease (CKD) Drugs Market Share Analysis

Chronic Kidney Disease (CKD) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease (CKD) Drugs business, the date to enter into the Chronic Kidney Disease (CKD) Drugs market, Chronic Kidney Disease (CKD) Drugs product introduction, recent developments, etc.

The major vendors covered:

- Pfizer, Inc.

- Amgen

- Roche

- GlaxoSmithKline (GSK)

- Allergan

- AbbVie

- Kissei Pharmaceutical Co., Ltd.

- ...

Global Chronic Kidney Disease (CKD) Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Chronic Kidney Disease (CKD) Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease (CKD) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Type
1.4.2 ACE inhibitors
1.4.3 Angiotensin-II receptor blockers
1.4.4 Calcium channel blockers
1.4.5 Beta blockers: BREVIBLOC, Bystolic
1.4.6 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease (CKD) Drugs Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales 2015-2026
2.2 Global Chronic Kidney Disease (CKD) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chronic Kidney Disease (CKD) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Kidney Disease (CKD) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chronic Kidney Disease (CKD) Drugs Competitor Landscape by Players
3.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers
3.1.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers
3.2.1 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease (CKD) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Drugs Revenue in 2019
3.2.5 Global Chronic Kidney Disease (CKD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Kidney Disease (CKD) Drugs Price by Manufacturers
3.4 Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease (CKD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Kidney Disease (CKD) Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease (CKD) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease (CKD) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease (CKD) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chronic Kidney Disease (CKD) Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease (CKD) Drugs Price by Application (2015-2020)
5.2 Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease (CKD) Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chronic Kidney Disease (CKD) Drugs by Country
6.1.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Country
6.1.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Type
6.3 North America Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Drugs by Country
7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Country
7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Type
7.3 Europe Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs by Region
8.1.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region
8.1.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chronic Kidney Disease (CKD) Drugs by Country
9.1.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country
9.1.2 Latin America Chronic Kidney Disease (CKD) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Type
9.3 Central & South America Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Country
10.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country
10.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products Offered
11.1.5 Pfizer, Inc. Related Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description and Business Overview
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Products Offered
11.2.5 Amgen Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Chronic Kidney Disease (CKD) Drugs Products Offered
11.3.5 Roche Related Developments
11.4 GlaxoSmithKline (GSK)
11.4.1 GlaxoSmithKline (GSK) Corporation Information
11.4.2 GlaxoSmithKline (GSK) Description and Business Overview
11.4.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Products Offered
11.4.5 GlaxoSmithKline (GSK) Related Developments
11.5 Allergan
11.5.1 Allergan Corporation Information
11.5.2 Allergan Description and Business Overview
11.5.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Products Offered
11.5.5 Allergan Related Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description and Business Overview
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Products Offered
11.6.5 AbbVie Related Developments
11.7 Kissei Pharmaceutical Co., Ltd.
11.7.1 Kissei Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Kissei Pharmaceutical Co., Ltd. Description and Business Overview
11.7.3 Kissei Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Products Offered
11.7.5 Kissei Pharmaceutical Co., Ltd. Related Developments
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products Offered
11.1.5 Pfizer, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chronic Kidney Disease (CKD) Drugs Market Estimates and Projections by Region
12.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Kidney Disease (CKD) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Kidney Disease (CKD) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chronic Kidney Disease (CKD) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Kidney Disease (CKD) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Kidney Disease (CKD) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Kidney Disease (CKD) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Kidney Disease (CKD) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Kidney Disease (CKD) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Kidney Disease (CKD) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Kidney Disease (CKD) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Kidney Disease (CKD) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Kidney Disease (CKD) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Kidney Disease (CKD) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Kidney Disease (CKD) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease (CKD) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease (CKD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Chronic Kidney Disease (CKD) Drugs Market Segments
Table 2. Ranking of Global Top Chronic Kidney Disease (CKD) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of ACE inhibitors
Table 5. Major Manufacturers of Angiotensin-II receptor blockers
Table 6. Major Manufacturers of Calcium channel blockers
Table 7. Major Manufacturers of Beta blockers: BREVIBLOC, Bystolic
Table 8. Major Manufacturers of Others
Table 9. Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Chronic Kidney Disease (CKD) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Chronic Kidney Disease (CKD) Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Chronic Kidney Disease (CKD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Chronic Kidney Disease (CKD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2019)
Table 18. Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Price (2015-2020) (USD/Unit)
Table 21. Chronic Kidney Disease (CKD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
Table 23. Date of International Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 26. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2015-2020)
Table 27. Global Chronic Kidney Disease (CKD) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2015-2020)
Table 29. Chronic Kidney Disease (CKD) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Application (2015-2020)
Table 32. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2015-2020) (K Units)
Table 33. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Chronic Kidney Disease (CKD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 37. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 39. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2015-2020) (K Units)
Table 41. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Chronic Kidney Disease (CKD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 45. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 47. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2015-2020) (K Units)
Table 57. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 61. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 63. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Table 72. Pfizer, Inc. Corporation Information
Table 73. Pfizer, Inc. Description and Major Businesses
Table 74. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Pfizer, Inc. Product
Table 76. Pfizer, Inc. Recent Development
Table 77. Amgen Corporation Information
Table 78. Amgen Description and Major Businesses
Table 79. Amgen Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Amgen Product
Table 81. Amgen Recent Development
Table 82. Roche Corporation Information
Table 83. Roche Description and Major Businesses
Table 84. Roche Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Roche Product
Table 86. Roche Recent Development
Table 87. GlaxoSmithKline (GSK) Corporation Information
Table 88. GlaxoSmithKline (GSK) Description and Major Businesses
Table 89. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. GlaxoSmithKline (GSK) Product
Table 91. GlaxoSmithKline (GSK) Recent Development
Table 92. Allergan Corporation Information
Table 93. Allergan Description and Major Businesses
Table 94. Allergan Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Allergan Product
Table 96. Allergan Recent Development
Table 97. AbbVie Corporation Information
Table 98. AbbVie Description and Major Businesses
Table 99. AbbVie Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. AbbVie Product
Table 101. AbbVie Recent Development
Table 102. Kissei Pharmaceutical Co., Ltd. Corporation Information
Table 103. Kissei Pharmaceutical Co., Ltd. Description and Major Businesses
Table 104. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Kissei Pharmaceutical Co., Ltd. Product
Table 106. Kissei Pharmaceutical Co., Ltd. Recent Development
Table 107. Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 108. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 112. North America: Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 114. Europe: Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Chronic Kidney Disease (CKD) Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 116. Asia Pacific: Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Latin America: Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Chronic Kidney Disease (CKD) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 120. Middle East and Africa: Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Chronic Kidney Disease (CKD) Drugs Players
Table 125. Chronic Kidney Disease (CKD) Drugs Customers List
Table 126. Chronic Kidney Disease (CKD) Drugs Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Kidney Disease (CKD) Drugs Product Picture
Figure 2. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. ACE inhibitors Product Picture
Figure 4. Angiotensin-II receptor blockers Product Picture
Figure 5. Calcium channel blockers Product Picture
Figure 6. Beta blockers: BREVIBLOC, Bystolic Product Picture
Figure 7. Others Product Picture
Figure 8. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Specialty Clinics
Figure 11. Chronic Kidney Disease (CKD) Drugs Report Years Considered
Figure 12. Global Chronic Kidney Disease (CKD) Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Chronic Kidney Disease (CKD) Drugs Sales 2015-2026 (K Units)
Figure 14. Global Chronic Kidney Disease (CKD) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region in 2019
Figure 17. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region in 2019
Figure 19. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Drugs Revenue in 2019
Figure 21. Chronic Kidney Disease (CKD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2019
Figure 24. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type in 2019
Figure 26. Global Chronic Kidney Disease (CKD) Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2019
Figure 29. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Application in 2019
Figure 31. North America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2019
Figure 34. North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Chronic Kidney Disease (CKD) Drugs Market Share by Type in 2019
Figure 40. North America Chronic Kidney Disease (CKD) Drugs Market Share by Application in 2019
Figure 41. Europe Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2019
Figure 44. Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Chronic Kidney Disease (CKD) Drugs Market Share by Type in 2019
Figure 56. Europe Chronic Kidney Disease (CKD) Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Region in 2019
Figure 61. China Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Share by Application in 2019
Figure 85. Latin America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Chronic Kidney Disease (CKD) Drugs
  • Global and United States Hemodialysis Powder Solution Market Report & Forecast 2022-2028
    Published: 12-May-2022        Price: US 4350 Onwards        Pages: 100
    Hemodialysis Powder Solution market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Hemodialysis Powder Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Hemodialysis Powd......
  • Global Hemodialysis Powder Solution Market Insights, Forecast to 2028
    Published: 20-Apr-2022        Price: US 4900 Onwards        Pages: 114
    Hemodialysis Powder Solution market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hemodialysis Powder Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Hemodialysis Concentrates - Hemodialysis Dry Powder Segment by Appl......
  • Global Hemodialysis Powder Solution Market Research Report 2021 - Impact of COVID-19 on the Market
    Published: 03-Mar-2022        Price: US 3000 Onwards        Pages: 113
    The Hemodialysis Powder Solution market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influence of COVID-19 on the global Hemodialysis Powder Solution market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on ana......
  • Global Chronic Kidney Disease (CKD) Drugs Market Insights and Forecast to 2028
    Published: 23-Feb-2022        Price: US 4900 Onwards        Pages: 94
    Chronic Kidney Disease (CKD) Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease (CKD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - ACE Inhibitors - Angiotensin-II Receptor Blockers - Calcium Cha......
  • Global Peritoneal Dialysis Solution Market Research Report 2021 - Impact of COVID-19 on the Market
    Published: 08-Feb-2022        Price: US 3000 Onwards        Pages: 125
    Peritoneal Dialysis Solution is a solution for peritoneal dialysis.Peritoneal dialysis is a treatment for kidney failure that uses the lining of your abdomen, or belly, to filter your blood inside your body. Health care providers call this lining the peritoneum. The Peritoneal Dialysis Solution market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influence of COV......
  • Global Hemodialysis Concentrates Market Insights and Forecast to 2028
    Published: 24-Jan-2022        Price: US 4900 Onwards        Pages: 125
    Hemodialysis Concentrates market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hemodialysis Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Acid Concentrates - Bicarbonate Concentrates Segment by Application......
  • Global Hemodialysis Concentrates Market Research Report 2022 Professional Edition
    Published: 18-Jan-2022        Price: US 2890 Onwards        Pages: 137
    The global Hemodialysis Concentrates market was valued at 20.53 Million USD in 2021 and will grow with a CAGR of 2.9% from 2021 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia,......
  • Global Hemodialysis Powder Solution Market Insights and Forecast to 2028
    Published: 17-Jan-2022        Price: US 4900 Onwards        Pages: 109
    Hemodialysis Powder Solution market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hemodialysis Powder Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Hemodialysis Concentrates - Hemodialysis Dry Powder Segment by Appl......
  • Hemodialysis Concentrates Market - Global Outlook and Forecast 2022-2028
    Published: 13-Jan-2022        Price: US 3250 Onwards        Pages: 129
    Hemodialysis concentrates including: Acid concentrates A-concentrate Acidified concentrated mixture of salts that, when diluted with dialysis water and bicarbonate concentrate, yields dialysis fluid for use in dialysis Note 1 to entry: The term "acid" refers to the small amount of acid (for example, acetic acid or citric acid) that is included in the concentrate. Note 2 to entry: Acid concentrate may contain glucose. Note 3 to entry: Acid concentrate may be in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs